Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ANI Pharmaceuticals, Inc. - Common Stock (NQ: ANIP )

58.46 +0.96 (+1.67%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ANI Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
ANI Pharma's Purified Cortrophin Gel Scores FDA Approval; Q3 Earnings Beat Estimates
ANI Pharmaceuticals Inc (NASDAQ: ANIP) has reported Q3 sales of $52.1 million, down 1.7% Y/Y, better than the consensus of $49.70 million. The company achieved an... 
Via Benzinga
Topics Earnings
Exposures Financial Product Safety
Mid-Afternoon Market Update: loanDepot Surges After Q3 Results; Mirati Therapeutics Shares Slide
Toward the end of trading Monday, the Dow traded up 0.12% to 35,863.70 while the NASDAQ rose 0.18% to 15,525.52. The S&P, however, fell 0.10% to 4,600.81. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
Dow, SPX Fall From Record Intraday Highs
Stocks are mixed at midday, with the Dow Jones Industrial Average reversing some of this morning's gains after briefly toppling the 36,000 level for the first time ever. 
Via Talk Markets
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's regular session. As of 12:30 EST, this security is trading at a volume... 
Via Benzinga
Here's Why Ani Pharmaceuticals Stock Is Rocketing Higher Today
The company reported positive third-quarter earnings, and the FDA granted approval for its generic version of Acthar Gel. 
Via The Motley Fool
Topics Bankruptcy Lawsuit
Exposures Financial Legal Product Safety
Mid-Day Market Update: Dow Rises 50 Points; ANI Pharmaceuticals Shares Jump
Midway through trading Monday, the Dow traded up 0.14% to 35,871.27 while the NASDAQ rose 0.23% to 15,534.49. The S&P also fell, dropping 0.03% to 4,603.98. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
Ani Pharma Rockets After Winning FDA Approval To Revive Old Merck Drug
Cortophin Gel gained approval to treat several autoimmune conditions. 
Via Investor's Business Daily
Exposures Product Safety
40 Stocks Moving In Monday's Mid-Day Session
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares jumped 250% to $8.91 on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the... 
Via Benzinga
ANI Pharmaceuticals's Return On Capital Employed Overview
According to Benzinga Pro data, during Q3, ANI Pharmaceuticals (NASDAQ:ANIP) posted sales of $52.06 million. Earnings were up 77.1%, but ANI Pharmaceuticals still reported an... 
Via Benzinga
Mid-Morning Market Update: Markets Mixed; PG&E Earnings Miss views
Following the market opening Monday, the Dow traded up 0.08% to 35,846.72 while the NASDAQ rose 0.18% to 15,527.04. The S&P also fell, dropping 0.07% to 4,602.32. The U.S. has... 
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's pre-market session. The company's market cap stands at $27.1... 
Via Benzinga
ANI Pharmaceuticals Reports Third Quarter 2021 Results
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Announces FDA Approval of Purified Cortrophin™ Gel for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis and Nephrotic Syndrome
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals to Discuss Third Quarter 2021 Financial Results on November 1, 2021
From ANI Pharmaceuticals, Inc.
Via Business Wire
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Gilead, Merck to Study Trodelvy-Keytruda Combo For Breast Cancer Gilead, Inc... 
Via Benzinga
Earnings Scheduled For November 1, 2021
Companies Reporting Before The Bell • ANI Pharmaceuticals (NASDAQ:ANIP) is expected to report earnings for its third quarter. • Kiniksa Pharmaceuticals (NASDAQ:... 
Via Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength... 
Via Benzinga
Exposures Product Safety
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned. Four new... 
Via Benzinga
ANI Pharmaceuticals to Present at Cantor Virtual Global Healthcare Conference 2021
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Announces Launch of Nebivolol Tablets
From ANI Pharmaceuticals, Inc.
Via Business Wire
Looking Into ANI Pharmaceuticals's Return On Capital Employed
Benzinga Pro data, ANI Pharmaceuticals (NASDAQ:ANIP) reported Q2 sales of $48.62 million. Earnings fell to a loss of $15.55 million, resulting in a 610.77% decrease from last... 
Via Benzinga
ANI Pharma's Purified Cortrophin Gel Application Under FDA Review
The FDA has accepted ANI Pharmaceuticals Inc's (NASDAQ: ANIP) supplemental marketing application for Purified Cortrophin Gel. The application seeks approval... 
Via Benzinga
Exposures Product Safety
ANI Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental New Drug Application for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis, and Nephrotic Syndrome
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals, inc (ANIP) Q2 2021 Earnings Call Transcript
ANIP earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: ANI Pharmaceuticals Q2 Earnings
Shares of ANI Pharmaceuticals (NASDAQ:ANIP) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share fell 2.90% year over year to $0.67,... 
Via Benzinga
ANI Pharmaceuticals Reports Second Quarter 2021 Results
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals to Discuss Second Quarter 2021 Financial Results on August 6, 2021
From ANI Pharmaceuticals, Inc.
Via Business Wire
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
Earnings Scheduled For August 6, 2021
Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of $154.00 million.... 
Via Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.